How to Check an NMN or NR Label Before You Buy
An NMN or NR label is a claim. It names the form and milligrams per serving, but it cannot show what is in your bottle. Before you buy, confirm the amounts, a certificate for the exact lot, and which tests an outside lab ran.
The short answer A label is a claim, and a certificate for your lot is the evidence. Before you pay, check the form named, the milligrams per serving, and whether the certificate names the lab, the method and the measured result. Labels can be far off. A 2024 test of NMN and urolithin A products found measured content from 28.6% above the label to 100% below it. A certificate can still prove less than it looks. Check which lot each test covers, and whether an outside lab tested the finished capsule or a blend. First step: match the full lot number on your bottle to the certificate for that lot.
NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are sold as precursors to NAD+, a coenzyme your cells use in energy metabolism. For the biology, start with our NAD+ longevity guide. Apply the checklist to any bottle. We also work one of our own certificates through it, line by line.
Why the answer isn't simple
The label and the bottle answer different questions. The label rule, 21 CFR 101.36, sets the format of the Supplement Facts panel: serving size, each listed dietary ingredient with its amount, and a Daily Value (the reference amount) where one exists. A proprietary blend can be declared as one total weight, the combined weight of the ingredients inside it. The panel governs how a claim is printed, not what the bottle holds.
Testing is a separate rule. A manufacturer must test a dietary ingredient's identity before using it, and must verify identity, purity, strength and composition in finished batches, either through a sound sampling plan or on every batch (21 CFR 111.75). The rule asks for documented testing, not a public certificate for each lot.
A buyer who reads "tested" may assume every bottle was checked, but the brand may test a sample of batches. A 2024 study makes the same point: government safety checks look for prohibited compounds, not label accuracy. Singapore researchers tested NMN and urolithin A products sold online and in pharmacies, and measured content ran from 28.6% above the label to 100% below it (PubMed 38935229). The abstract gives the range but not the number of products, so treat it as a warning, not a rate. Our urolithin A buying guide covers the same uneven category, and the urolithin A monograph covers the ingredient.
Does the form change what the body receives?
The human data say less about form than a label implies. The seven studies below cover the forms labels name. Most are pharmacokinetic studies, which track how the body absorbs, distributes and clears a dose.
Nicotinamide riboside, single doses (2016). Trammell and colleagues gave single oral doses of 100, 300 and 1,000 mg of NR and tracked the blood NAD metabolome. Levels rose with dose, and in one pilot participant blood NAD climbed as much as 2.7-fold (PubMed 27721479). The abstract gives no group size for the dose study, and two authors list ChromaDex, Inc. as an affiliation. Grade for blood NAD rise: Preliminary, a pharmacokinetic study, and the abstract mentions no placebo group.
Nicotinamide riboside, repeated doses (2017). Airhart and colleagues gave eight healthy adults 250 mg of NR for two days, then up to 1,000 mg twice a day. Whole-blood NAD+ rose 100% from baseline to steady state, the level reached after repeated dosing (p = 0.001) (PubMed 29211728). The study was open-label and non-randomized. Grade for blood NAD+ rise: Preliminary.
NMN against placebo (2022). Okabe and colleagues randomized 30 healthy adults to 250 mg of NMN a day or placebo for 12 weeks. Whole-blood NAD rose significantly in the NMN group, and safety tests showed no abnormalities (PubMed 35479740). NMN itself did not rise significantly, while a related compound, nicotinic acid mononucleotide (NAMN), did. Four authors list Mitsubishi Corporation Life Sciences as an affiliation, and the grade for blood NAD rise is Moderate, from a small placebo-controlled trial.
NMN, single doses (2019). Irie and colleagues gave ten healthy Japanese men one oral dose of 100, 250 or 500 mg of NMN and followed them for five hours. Plasma levels of two breakdown products, 2PY and 4PY, rose with dose, and no significant symptoms were reported (PubMed 31685720). The abstract reports breakdown products, not NAD+. Grade for breakdown products: Preliminary.
NR and NMN, head to head (2026). Christen and colleagues ran a randomized, open-label, placebo-controlled study of 65 healthy adults for 14 days, comparing NR, NMN and nicotinamide (PubMed 41540253). Circulating NAD rose comparably with NR and NMN, and nicotinamide did not raise it over that period. The abstract gives no doses, so this page quotes none. Most authors list Nestlé as an affiliation, and the grade for NAD rise over 14 days is Moderate, from a randomized trial.
Oral versus sublingual NMN (2026). Wakabayashi and colleagues gave 14 healthy men a single dose of NMN by mouth and, after an eight-day washout, a single dose under the tongue, in a crossover design (PubMed 42304075). Blood NMN, nicotinamide and NAD+ did not differ significantly by route. The breakdown products 2PY and 4PY rose faster under the tongue during the first hour, and the authors could not say where they came from. All three authors list Meiji Holdings as an affiliation. Grade for blood NMN and NAD+: Preliminary, a small crossover trial with one dose.
Long dosing at 1,200 mg a day (2026). Berven and colleagues gave six healthy adults and six people with Parkinson's disease 1,200 mg a day of NR or NMN, then tracked NAD in blood and brain (PubMed 41858901). Blood NAD leveled off after about two weeks, and brain NAD rose after four weeks. Responses varied widely. It is an early-phase trial, and the abstract mentions no placebo group. Grade for NAD rise: Preliminary.
Taken together, a single dose tells you about absorption, a few weeks tell you about blood levels, and nothing here tells you about years of use. A 2025 review in Nature Aging says large studies are still needed to settle the best dose, route and frequency (PubMed 40926126).
Which label to trust, by situation
Each row gives a situation, the check to make, and the reason. Find your situation first, because the same label can be sound for one question and weak for a different one.
| Your situation | What to check | Why it matters |
|---|---|---|
| You want NMN | Milligrams of NMN per serving, and an HPLC result for NMN on the certificate | The NMN studies here used 100 to 500 mg as single doses, or 250 mg a day. |
| You want NR | The salt named, and whether the milligrams are NR or salt weight | Our PubMed search found no human study comparing NR salts. |
| You want sublingual or liposomal (fat-based particles) | A human study of that exact form | The sublingual trial we found showed no difference in blood NMN or NAD+. Our PubMed search found no randomized human pharmacokinetic study of liposomal NMN. |
| You want NMN and NR in one bottle | Milligrams for each precursor, on separate lines | A proprietary blend can show one total, so two precursors can share one number. |
| The label says "third-party tested" | A lot number on the bottle, and a certificate for that exact number | A claim with no certificate is still only a claim. |
| The certificate covers another lot, or a blend | Which lot each test covers | A test on a blend, or on another lot, tells you less about the bottle in your hand. |
| You take prescription medicine, or are pregnant or nursing | The label's advice to ask a practitioner first | The longest duration we could verify here is 12 weeks. |
Every row comes down to one rule: match the claim to a record for the lot in your hand. Without that record, you are only trusting the brand's word. Keep the lot number and the certificate together, because a label is only as good as the lot behind it.
How do you check a bottle against its certificate?
What a certificate should show
The testing rule sets no certificate format for finished products. Its closest guide is the supplier standard in 21 CFR 111.75(a)(2)(ii)(B), which requires a certificate a manufacturer relies on to describe the test method, the limits and the actual results. A usable certificate names the lab, the method, the lot, each result and its limit.
How to match the certificate to your bottle
Find the lot number printed on the bottle or carton, then open the certificate for that lot. Compare the whole string, character for character. Some brands number the blend, the encapsulated lot and the finished lot separately, so check which number each test names. If the lot is not listed, ask the brand for that lot's certificate in writing, and keep the reply with your receipt.
Questions to ask before you pay
- Which lab ran each test, and is it independent of the brand?
- Was the test run on the finished capsule or on a blend?
- Which lot does each result cover, and is there a separate identity test?
- Which supplier made the NMN or NR, and what is its FDA notification number? FDA's public list of new dietary ingredient notifications includes an NMN entry, NDIN 1444, submitted November 17, 2025, with FDA's response dated January 28, 2026. The list shows dates, not conclusions.
Count servings, not capsules. A 60-capsule bottle at two capsules a serving holds 30 servings, so divide the price by 30 for the price per day. Compare that number across brands.
A worked example: one lot of our NMN + NR
The product page links a certificate for lot 0077634. Its issue date is April 6, 2026, and its manufacture date is October 30, 2025. The lot field reads 0077634-015-M1026-103025-00002, so match the whole string.
Five actives are measured per two-capsule serving, and every result falls between 122.5% and 122.9% of its label claim. NMN measured 614.2 mg against 500 mg by HPLC (high-performance liquid chromatography). Nicotinamide riboside measured 245 mg against 200 mg, also by HPLC. TMG (trimethylglycine) measured 61.46 mg against 50 mg, and zinc 12.29 mg against 10 mg by ICP-MS, a metals-testing method. Resveratrol measured 307.3 mg against 250 mg, but its method column reads "By Input" rather than naming a test.
The 614.2 mg figure comes from Highland's own HPLC on finished capsules. The outside lab, MS Bioanalytical in Champaign, Illinois, tested the pre-encapsulation blend and reported 468.4 mg of NMN per gram. That third-party test was run on blend lot 0077635, not the lot the certificate covers. Every other result came from Highland's own lab on finished capsules.
Heavy metals and microbes also appear. Per serving, arsenic is 0.12 mcg against a 10 mcg limit, lead 0.41 against 6, cadmium 0.24 against 4.1, and mercury 0.10 against 2. Total aerobic count, yeast and mold, total coliforms and E. coli are not detected.
The certificate also has gaps. It has no identity line and lists no expiration date. It has no test for piperine, the black pepper extract the label lists as Bioperine at 50 mg. Its only outside result covers a blend under another lot number. None of these gaps is a failed result, but they limit what the certificate can tell you. The lab-testing page lists two lots of this product.
Our product, read against this checklist
Our NMN + NR with Resveratrol and TMG is a 60-capsule bottle, two capsules a serving, 30 servings. Its label lists 500 mg of NMN and 200 mg of NR per serving, plus resveratrol, TMG, Bioperine and zinc. At $59.99, that is $2.00 a day. The NMN amount is at the top of the 100 to 500 mg range in the studies above. The NR amount is one-sixth of the 1,200 mg a day in the 2026 trial and falls between the 100 mg and 300 mg single doses in the 2016 study. See the current price and label.
When should you stop and ask a clinician?
Five of the seven studies enrolled healthy volunteers only, so they say little about people with a medical condition. Berven and colleagues tested six people with Parkinson's disease, but that group was small. The studies that report safety describe few or no adverse effects. Okabe and colleagues found no abnormalities in physiological and laboratory tests (PubMed 35479740), and Irie and colleagues reported no significant symptoms (PubMed 31685720). None of them establishes long-term safety. Ask a clinician before you start if you take prescription medicine, are pregnant or nursing, or have a medical condition, as the product label advises. If new symptoms appear, stop and contact a clinician.
Next reads
- Deeper: The NMN monograph covers the human NMN trials in more detail.
- Across: Supplement label and testing basics covers reading a label and third-party testing.
- Commercial: Our NMN and NR buying guide ranks the products on the market, ours included.
Related reading
- The FDA timeline behind NMN's legal status
- Nicotinamide riboside: the human NR trials
- NMN and NR doses compared with the trials
- How to read a black pepper extract (piperine) line
The Bottom Line
Check the form, milligrams per serving and lot, in that order. Trust a bottle only when its lot number matches a certificate naming the lab, the method and the measured result, and the outside test covers the finished capsule. In one 2024 test, measured content ran from 28.6% over label to 100% under. Next step: match the full lot number, then divide the price by the servings.
Related Products
NMN + NR with Resveratrol and TMG – NAD+ & Cellular Energy Support | 60 Capsules
$59.99
FAQ
What must an NMN or NR supplement label show under US rules, and what can it leave out?
Under 21 CFR 101.36, the Supplement Facts panel must show the serving size, each listed dietary ingredient with its amount per serving, and a Daily Value where one exists. A proprietary blend can be declared as one total weight. Nothing in the panel requires a test result or a certificate, so read it as the brand's claim, then check the lot.
What does per serving mean, and why do capsule counts and proprietary blends mislead buyers?
Per serving means per the brand's chosen serving size, so bottle counts mislead. A 60-capsule bottle at two capsules a serving holds 30 servings. Two brands can print the same milligrams per capsule and differ on capsules per serving, which changes the daily dose. A proprietary blend shows one total weight, so you cannot see how much of any one active it holds.
Which form of NMN or NR is named on the label, and does the form change what the body receives?
So far the human data show little difference by form in blood NAD. In a 14-day trial of 65 adults, NR and NMN raised circulating NAD comparably. In 14 men, oral and sublingual NMN gave no significant difference in blood NMN or NAD+, though two breakdown products rose faster under the tongue. Ask which form the brand uses and what study supports it. The [NMN monograph](/ingredients/nmn-nicotinamide-mononucleotide) covers the human NMN trials.
What is a certificate of analysis, and what should one show for an NMN or NR lot?
A certificate of analysis is the record of tests run on one lot. For an NMN or NR lot, it should name the lot, the lab, the method, each result and its limit. Look for identity, potency, contaminants and microbes. The federal supplier standard asks for the method, the limits and the actual results (21 CFR 111.75(a)(2)(ii)(B)).
How do you match a certificate to the bottle you bought?
Find the lot number on the bottle or carton, then open the certificate for that same lot. Compare the full string, not the first few digits, because a neighboring lot can share the same start. Some brands number the blend and the finished lot separately, so check which lot each test names. If the lot is not listed, ask the brand for that lot's certificate in writing.
Which testing claims can a buyer verify, and which are marketing?
A testing claim is verifiable when a lot-level certificate names the lab, the method and a measured result, and the claim matches what that certificate covers. A 'third-party tested' label with no certificate is only a claim. Ask for the lab's accreditation, then check the test's scope, since a blend test is not a finished-capsule test. For more on reading these claims, see the [supplement safety and testing guide](/health/vitamin-d-complete-guide/supplement-safety-quality-testing-guide).
What questions should a buyer ask a brand before paying?
Ask which lab ran each test, whether that lab is independent of the brand, and which lot each result covers. Ask which supplier made the NMN or NR, and for that supplier's FDA notification number. FDA's public list includes an NMN notification, NDIN 1444, submitted November 17, 2025. If a brand cannot answer these questions in writing, treat its label as unverified.